Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05214144 · ClinicalTrials.gov registry record
The In4M Study: Integrating 4 Methods to Assess Physical Function in Cancer Patients
A clinical trial of Lymphoma and Quality of Life, sponsored by Yale University.
- Completed
- Registry status
- 208
- Enrollment target
- 2
- Study locations
NCT05214144 is a study of Lymphoma and Quality of Life that has completed, run by Yale University. The registered enrollment target is 208 participants, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (57% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05214144, a study of Lymphoma and Quality of Life, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 208 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a prospective observational cohort study. Breast cancer and lymphoma patients planned to receive cytotoxic therapy will be recruited at Yale and Mayo Clinic. The Study Period is 9 months, during which enrolled patients will use their personal smartphone, computer, or other web-connected device to connect with the Hugo platform which will deliver PRO questionnaires, and sync to the wearable device in the study (Fitbit). The PerfO (6MWT) will be conducted twice in clinic during the study period. Structured information from the electronic health record (EHR) and patient portals will be collected and where needed, the EHR will be directly reviewed to record AEs, hospitalizations/emergency department visits and dose delay/reductions. Required in-person face to face visit is only at baseline for consent, enrollment and receipt of wearable device; patients can be followed remotely afterward (i.e. do not need to be treated at Mayo or Yale)
Conditions Studied
Interventions
- DEVICE Fitbit
- OTHER PRO Instruments assessment questionnaire
- OTHER Baseline Survey Clinician- reported (ClinRO) ECOG
- OTHER Hugo Health ("Hugo")
- OTHER 6 Minute Walk Test (6MWT)
Study Locations (2)
Connecticut
- Yale Cancer Center - New Haven
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2022-01-27 |
| Est. Completion | 2024-10-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05214144
The ClinicalTrials.gov registry entry for NCT05214144 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (57% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Lymphoma appearing as the primary indexed condition, and to 5 interventions - of which Fitbit is the first listed.
NCT05214144 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, Minnesota.
Frequently Asked Questions
What is clinical trial NCT05214144 about?
NCT05214144 is a clinical study titled "The In4M Study: Integrating 4 Methods to Assess Physical Function in Cancer Patients". This is a prospective observational cohort study. Breast cancer and lymphoma patients planned to receive cytotoxic therapy will be recruited at Yale and Mayo Clinic. The Study Period is 9 months, during which enrolled patients will use their personal smartphone, computer, or other web-connected devi...
What is the current status of trial NCT05214144?
This trial is currently completed. The enrollment target is 208 participants. The study started on 2022-01-27. Estimated completion is 2024-10-24.
What conditions does trial NCT05214144 study?
This clinical trial studies the following conditions: Lymphoma, Quality of Life, Cancer, Breast, Physical Function, Patient Education.
What interventions are being tested in trial NCT05214144?
The interventions under investigation include: Fitbit (DEVICE), PRO Instruments assessment questionnaire (OTHER), Baseline Survey Clinician- reported (ClinRO) ECOG (OTHER), Hugo Health ("Hugo") (OTHER), 6 Minute Walk Test (6MWT) (OTHER).
Who is sponsoring clinical trial NCT05214144?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05214144 being conducted?
This trial has 2 study locations across Connecticut, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
RECRUITING · NA
-
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
RECRUITING · Early Phase 1
-
A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma
RECRUITING · Phase 1
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.